Related Experiment Video
Updated: Mar 31, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Quality of Clinical Practice Guidelines for Diabetic Foot Management: A Systematic Review Using the AGREE II and
Yu Song1, Zhong-Fei Cui2, Zhi-Qiang Wu1
1Department of Burns, Plastics and Wound Repair Surgery, The First Affiliated Hospital of Dali University, Dali University, Dali, Yunnan, 671000, People's Republic of China.
Clinical practice guidelines for diabetic foot ulcer (DFU) management show methodological strengths but need improvement in applicability and stakeholder involvement. Enhancing these areas and evidence quality is key for better DFU care.
Area of Science:
- Medical Guidelines
- Diabetology
- Wound Care
Background:
- Diabetic foot ulcers (DFUs) represent a significant complication of diabetes, necessitating high-quality clinical practice guidelines (CPGs) for effective management.
- Evaluating the methodological rigor and recommendation quality of existing DFU CPGs is crucial for optimizing patient care and guiding future guideline development.
Purpose of the Study:
- To assess the methodological quality of DFU management CPGs using the AGREE II and AGREE-REX instruments.
- To evaluate the excellence and synthesize clinical treatment recommendations within these DFU CPGs.
- To grade the evidence supporting synthesized DFU treatment recommendations using the OCEBM system.
Main Methods:
- A systematic literature search identified DFU CPGs published between January 1, 2015, and May 1, 2025.
- Guideline quality was appraised using the AGREE II and AGREE-REX tools by independent reviewers.
- Clinical treatment recommendations were synthesized and evidence graded using the Oxford Centre for Evidence-Based Medicine (OCEBM) system.
Main Results:
- Fifteen CPGs were included, categorized as 6 high-quality and 9 moderate-quality.
- Highest AGREE II scores were for Editorial Independence and Scope and Purpose; lowest was Applicability.
- AGREE-REX showed lowest scores for Values and Preferences, while Clinical Applicability and Implementability scored well.
- Seventeen key DFU treatment recommendations were synthesized, predominantly Grade B, supported by moderate-quality evidence.
Conclusions:
- DFU CPGs are generally developed systematically but exhibit limitations in applicability, stakeholder involvement, and rigor.
- The quality of recommendations is inconsistent, particularly concerning the consideration of patient values and preferences.
- Future guideline development should prioritize enhancing applicability, stakeholder engagement, rigor, and the quality of underlying evidence to improve DFU management strategies.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

